Found 5 matching trials
Ramosetron, Aprepitant and Dexamethasone (RAD) in Solid Cancer PHASE2 Cisplatin is one of the most emetogenic drugs used in clinical practice and...
Show More Location
Hallym University Sacred Heart Hospital
Learn More & Join Trial
Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis NA The purpose of this study is to determine how automated recommendations are...
Show More Location
Vanderbilt University Medical Center
Learn More & Join Trial
Safety and Efficacy of Aprepitant, Ramosetron, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Patients With Ovarian Cancer Treated With Taxane/Carboplatin PHASE2 The current recommended guideline for patients receiving moderately emetoge...
Show More Location
Samsung Medical Center
Learn More & Join Trial
Ramosetron, Aprepitant, and Dexamethasone Versus Palonosetron, Aprepitant, and Dexamethasone PHASE4 The purpose of this study is to compare the anti-emetic effect of ramosetro...
Show More Location
St. Vincent'S Hospital
Learn More & Join Trial
Ramosetron, Aprepitant and Dexamethasone Versus Ondansetron, Aprepitant and Dexamethasone PHASE3 The purpose of this study is to assess the efficacy and safety of Ramosetro...
Show More Learn More & Join Trial